StonvexLoading…
StonvexStonvexStonvexCore line items from PXS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $38.99M | $51.54M | $45.47M | $58.34M |
Operating Income | $5.92M | $16.72M | $41.87M | $17.31M |
Net Income | $1.99M | $12.87M | $37.04M | $13.39M |
EPS (Diluted) | $0.19 | $0.91 | $2.94 | $1.06 |
Total Assets | $193.41M | $188.88M | $166.31M | $138.98M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $35.55M | $21.24M | $34.54M | $7.56M |
Free Cash Flow OCF − CapEx | Not available | $-26.12M | $-7.06M | $5.28M |
Shares Outstanding | 10.42M | 10.55M | 10.54M | 10.61M |